Lux Capital

From Wikipedia, the free encyclopedia
Lux Capital
Type Private
Industry Venture capital
Founded 2000
Founder(s) Peter Hébert
Robert Paull
Josh Wolfe
Headquarters New York, NY, USA
Website luxcapital.com

Lux Capital is a venture capital firm founded by Peter Hébert, Robert Paull, and Josh Wolfe[1] in 2000[2] . The firm invests in emerging technologies in the physical and life sciences.[3][4]

The firm is based in New York, with partners also located in Palo Alto and San Diego. The Lux Capital team has built more than 20 companies from scratch.[3]

Lux's principals have been interested in developing improved methods for the treatment or remediation of nuclear waste, to assist the nuclear power industry.[3]

Lux Capital's portfolio companies include Accelergy,[5] Cambrios, Cerulean Pharma,[4] Crystal IS, Everspin,[2] Genocea Biosciences,[2][4] GridCo, Kala Pharmaceuticals,[4] Kereos, Kurion, Kymeta, Lux Research, Luxtera,[3] Magen Biosciences, Molecular Imprints, Nanosys, Visterra,[6] QD Soleil, SiBEAM, Shapeways, Silicon Clocks, Siluria Technologies, and Transphorm.[7]

In April 2011, former McKinsey Senior Partner Richard N. Foster and former CIA Director James Woolsey joined Lux Capital as venture partners.[8]

In August 2012, form Pfizer Chairman and CEO Jeff Kindler joined Lux Capital as a venture partner.[9]

With offices in New York and Palo Alto, California, Lux manages about $350 million in assets.[10]

See also

References

  1. ↑ Fickenscher, Lisa (2003). "2003 40 Under 40". Crain's New York Business. Jan 27 - Feb 2, 2003: 15–31. ISSN 8756-789X. OCLC 11620213. 
  2. ↑ 2.0 2.1 2.2 Eden, Scott (2009). "Nano Wunderkinds". Dealmaker. December/January 2009: 35–37. ISSN 1937-304X. OCLC 132936538. 
  3. ↑ 3.0 3.1 3.2 3.3 Bigelow, Bruce V. (6 May 2009). "Lux Capital’s Larry Bock and Josh Wolfe Warm to Venture Deals Despite Nuclear Winter". Xconomy. Retrieved 17 January 2010. 
  4. ↑ 4.0 4.1 4.2 4.3 Timmerman, Luke (23 Dec 2009). "Kala Pharmaceuticals, Stealthy New Company Tied to MIT’s Bob Langer, Gets $2M". Xconomy. Retrieved 18 January 2010. 
  5. ↑ Bullis, Kevin (25 Jan 2010). "Cleaner Jet Fuel from Coal". Technology Review. Retrieved 1 February 2010. 
  6. ↑ Lang, Michelle (12 Jul 2010). "Visterra takes in $6M VC funds, launches Singapore arm". Xconomy. Retrieved 1 June 2011. 
  7. ↑ Roushe, Wade (23 Feb 2011). "Google Ventures Leads $20M Round for Transphorm to Battle Hidden Tax in Power Conversion". Xconomy. Retrieved 25 February 2010. 
  8. ↑ "James Woolsey and Richard Foster Join Lux Capital as Venture Partners". Business Wire. 26 April 2011. 
  9. ↑ "Kindler, Former Pfizer Chief, Joins Lux Capital". Dealbook. 8 August 2012. 
  10. ↑ "Lux Capital Raises $245 Million to Fund Unpopular Science Startups". Bloomberg. 13 February 2013. 

External links

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.